CLINICAL_TRIALS
trial_result
· 2022-08-18
Clinical Trial Update: Preemptive Acetaminophen for Postoperative Pain Control Following Minimally Invasive Hysterectomy [Phase 2, Phase 3]
Summary
A Phase 2/3 trial evaluating preemptive acetaminophen for postoperative pain control after minimally invasive hysterectomy was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Montefiore Medical Center | Conditions: Post Operative Pain | Phase 2, Phase 3 | Status: WITHDRAWN